DUSP18 and colorectal carcinoma: In addition, Lumacaftor treatment in shDUSP18 CRC cell lines did not further down-regulate the protein levels of USF1 and SREBP2, indicating that the effect of Lumacaftor is DUSP18-dependent (Fig. 7h).